Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation

Trial Profile

GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Jul 2019

At a glance

  • Drugs Ticagrelor (Primary) ; Aspirin; Clopidogrel
  • Indications Cardiovascular disorders; Coronary artery disease; Thrombosis
  • Focus Adverse reactions
  • Acronyms GLOBAL-LEADERS
  • Most Recent Events

    • 18 Mar 2019 Results of post hoc analysis assessing long term safety of Ticagrelor monotherapy presented at the 68th Annual Scientific Session of the American College of Cardiology
    • 18 Mar 2019 Results of pre-specified subgroup analysis comparing the experimental strategy of ticagrelor monotherapy (after 1 month of ticagrelor and aspirin) with the reference 12-month dual antiplatelet therapy (DAPT) presented at the 68th Annual Scientific Session of the American College of Cardiology
    • 25 Sep 2018 Results assessing all cause mortality by Logistic Clinical SYNTAX (LCS) score after PCI, presented at the 30th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top